serine and metallo-beta-lactamase inhibitor

oral activity in resistant infection model

from optimization of literature starting point

J. Med. Chem., Apr. 2, 2020

Qpex Biopharma, San Diego, CA

QPX7728 is an ultrabroad-spectrum beta-lactamase inhibitor with activity against both serine and zinc metallo-beta-lactamases, in contrast to approved beta-lactamase inhibitors such as relebactam which are only active against serine metalloproteases.…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.